Matches in Wikidata for { <http://www.wikidata.org/entity/Q64708743> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q64708743 description "clinical trial" @default.
- Q64708743 description "ensayu clínicu" @default.
- Q64708743 description "klinisch onderzoek" @default.
- Q64708743 description "клінічне випробування" @default.
- Q64708743 name "Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia" @default.
- Q64708743 type Item @default.
- Q64708743 label "Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia" @default.
- Q64708743 prefLabel "Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia" @default.
- Q64708743 P1050 Q64708743-7800B278-1593-44CB-AE93-2F5F6DD6DF1A @default.
- Q64708743 P1132 Q64708743-55696F5F-D461-446C-88C7-E0BF824EC084 @default.
- Q64708743 P1476 Q64708743-5D61A527-EC79-4B8E-B1C7-BDE1E9F6B823 @default.
- Q64708743 P17 Q64708743-4926846F-5627-4B4A-BBF7-D0BB2A69FC71 @default.
- Q64708743 P17 Q64708743-49B162FB-3C4F-4E20-9C3E-3289F1E2E982 @default.
- Q64708743 P17 Q64708743-AC37530C-ECA4-43CB-BA45-3EE564022902 @default.
- Q64708743 P17 Q64708743-AD4B51B1-04A0-43B0-932A-C77E0AD6C4A2 @default.
- Q64708743 P17 Q64708743-AE0A1D55-BC2D-4940-8880-B17D2BBC0F56 @default.
- Q64708743 P17 Q64708743-D13D2449-C017-4248-9327-8ED0E23BE56F @default.
- Q64708743 P17 Q64708743-E607EDCC-721C-45A5-9FD6-238461A5BD70 @default.
- Q64708743 P2899 Q64708743-18C07AD3-771E-4F2D-AAEC-30923641DF59 @default.
- Q64708743 P3098 Q64708743-4EE6105C-29C2-4FF2-91D5-EE20F0566964 @default.
- Q64708743 P31 Q64708743-060A7030-39CE-4B84-A156-C4B100D0CDCF @default.
- Q64708743 P4844 Q64708743-D0C6444D-8290-4BAE-ABE3-AEEDDDDBF397 @default.
- Q64708743 P580 Q64708743-7F10023D-FDF1-45E7-A6BD-11F0290D32D0 @default.
- Q64708743 P582 Q64708743-E2B77747-8097-4421-83A0-3181C1785B84 @default.
- Q64708743 P6099 Q64708743-F40659BF-6B44-451B-A1C7-B41FBC81EEE9 @default.
- Q64708743 P6153 Q64708743-3F275A1B-4811-4109-846C-5C999C92CF8F @default.
- Q64708743 P8363 Q64708743-6F9A359F-80D2-41F6-8A34-250A0737BF37 @default.
- Q64708743 P1050 Q29496 @default.
- Q64708743 P1132 "+180" @default.
- Q64708743 P1476 "An Open Phase I/IIa Trial to Investigate the Maximum Tolerated Dose, Safety, Pharmacokinetics, and Efficacy of Intravenous BI 6727 as Monotherapy or in Combination With Subcutaneous Cytarabine in Patients With Acute Myeloid Leukaemia" @default.
- Q64708743 P17 Q142 @default.
- Q64708743 P17 Q16 @default.
- Q64708743 P17 Q183 @default.
- Q64708743 P17 Q20 @default.
- Q64708743 P17 Q31 @default.
- Q64708743 P17 Q38 @default.
- Q64708743 P17 Q40 @default.
- Q64708743 P2899 "+18" @default.
- Q64708743 P3098 "NCT00804856" @default.
- Q64708743 P31 Q30612 @default.
- Q64708743 P4844 Q180983 @default.
- Q64708743 P580 "2008-11-27T00:00:00Z" @default.
- Q64708743 P582 "2012-03-09T00:00:00Z" @default.
- Q64708743 P6099 Q42824440 @default.
- Q64708743 P6153 Q833670 @default.
- Q64708743 P8363 Q78089383 @default.